SLQT
$0.64
SelectQuote, Inc.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
SelectQuote, Inc. operates a technology-enabled, direct-to-consumer distribution and engagement platform that sells insurance policies and healthcare services in the United States. The company operates through three segments: Senior, Healthcare Servi...
Recent News
SelectQuote (SLQT) Reports 12% Revenue Growth, Supported Liquidity Through $415M Refinancing
SelectQuote Inc. (NYSE:SLQT) is one of the best penny stocks under $1 to buy right now. On February 5, SelectQuote reported a 12% year-over-year revenue increase to $537 million for FQ2 2026, driven by a strong performance in its senior segment and a 26% revenue jump for SelectRx. To support its expansion, SelectQuote secured a […]
How The SelectQuote (SLQT) Narrative Is Resetting As Fair Value Targets Recalibrate
SelectQuote’s updated analyst narrative now centers on a fair value move from $4.50 to about $3.06 per share, a sizable reset in where some models see the stock’s potential. Bulls view this shift as a cleaner, more execution focused starting point, while bears see it as a sign that earlier expectations were too aggressive. As you read on, you will see how to track these evolving views and what to watch if you are following the story. Stay updated as the Fair Value for SelectQuote shifts by...
SelectQuote, Inc. (SLQT) Implements Strategic and Financial Initiatives to Support Expansion
SelectQuote, Inc. (NYSE:SLQT) is one of the best NYSE penny stocks to buy now. On January 15, SelectQuote, Inc. (NYSE:SLQT) announced that its SelectRx pharmacy has signed a new multi-year agreement with a major pharmacy benefit manager (PBM), effective January 1, 2026. The agreement paves the way for greater visibility into reimbursement rates while offering […]
SelectQuote Q2 Earnings Call Highlights
SelectQuote (NYSE:SLQT) management highlighted what it described as a “strong quarter” driven by solid execution during the Medicare Advantage annual enrollment period (AEP), continued growth in its Healthcare Services segment, and recently announced financing and pharmacy benefit manager (PBM) agre
After Plunging 27.0% in 4 Weeks, Here's Why the Trend Might Reverse for SelectQuote (SLQT)
The heavy selling pressure might have exhausted for SelectQuote (SLQT) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.